Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Trial Profile

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2015

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms REACH
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 24 Mar 2015 Pooled analysis results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
    • 20 Dec 2010 Results published in the Archives of Dermatology .
    • 11 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top